• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Genomics PLC

Oxford’s Genomics Pushing the Boundaries of Personalized Medicine

April 13, 2021
SomaLogic (Alumni)

Proteomics company SomaLogic to chase $1.2B public valuation through SPAC deal

April 13, 2021
Inscripta (Alumni)

Inscripta closes $150M VC round, scores first commercial buyer of CRISPR gene editing platform

April 13, 2021
Inscripta (Alumni)

Having shipped its first benchtop gene editing devices, Inscripta draws another $150M from deep investor well

April 5, 2021
Lyell Immunopharma

Lyell Completes Cutting-Edge $65 Million Cell Therapy Facility

April 5, 2021
Crossover Health, Inc. (Alumni)

Crossover Health banks $168M Series D

April 5, 2021
Genomics PLC

Oxford’s Genomics Pushing the Boundaries of Personalized Medicine

April 2, 2021
Genomics PLC

Entrepreneurs: Meet Genomics founder Sir Peter Donnelly as biotech firm takes DNA analysis trials to America

April 2, 2021
Color Health

Inside Color’s big — and highly bankrolled — pivot to public health tech

March 27, 2021
Everly Health

Everlywell acquires two healthcare companies and forms parent Everly Health

March 27, 2021
Page 9 of 27« First«...7891011...20...»Last »

Please see important disclaimers in the Terms section.


©2026 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©[current_date] Foresite Capital Management, LLC.

    Site by Goodlab

    Close